Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Open-market purchases by insiders.
Insider buying
Traded Oct 22 · filed 1 day later
Since the trade −10.8%
The CEO of Aim Immunotech paid $5.1K out of pocket for Aim Immunotech shares. Shares held went up 25% with this purchase.
Traded Oct 15 – Oct 22, 2026 · largest single transaction ~$152K
Oct 21, 2026~$152K · 15K sh @ $10.33
DetailsOfficial recordOct 20, 2026~$106K · 10K sh @ $10.24
DetailsOfficial recordOct 15, 2026~$60K · 5,692 sh @ $10.47
DetailsOfficial recordOct 22, 2026~$35K · 3,322 sh @ $10.42
DetailsOfficial recordInsider buying
Traded Oct 22 · filed 1 day later
Since the trade −6.7% · S&P 500 −1.3% · to Nov 13
The CEO of Uxin paid $6.2K out of pocket for Uxin shares. 1 other person at Uxin bought some too, in the same month. Shares held went up 6% with this purchase.
Traded Oct 19 – Oct 22, 2026 · largest single transaction ~$44K
Oct 19, 2026~$44K · 9,971 sh @ $4.39
DetailsOfficial recordOct 21, 2026~$42K · 9,513 sh @ $4.46
DetailsOfficial recordOct 20, 2026~$43K · 9,794 sh @ $4.36
DetailsOfficial recordOct 22, 2026~$40K · 8,989 sh @ $4.40
DetailsOfficial recordTraded Oct 21 – Oct 22, 2026 · largest single transaction ~$20K
Oct 21, 2026~$20K · 5,700 sh @ $3.50
DetailsOfficial recordOct 22, 2026~$20K · 5,700 sh @ $3.50
DetailsOfficial recordInsider buying
11 days before resultsTraded Oct 16 · filed 7 days later
Since the trade +4.1% · S&P 500 −1.2% · to Nov 13
A First Financial director paid $6.4K out of pocket for First Financial shares. It was the first purchase in 19 months.
Insider buying
6 days before resultsTraded Oct 22 · filed the same day
Since the trade −1.4% · S&P 500 −1.3% · to Nov 13
A Rapport Therapeutics director paid $974K out of pocket for Rapport Therapeutics shares. 6 other people at Rapport Therapeutics bought some too, in the same month. It was the first purchase in 13 months.
Insider buying
6 days before resultsTraded Oct 22 · filed the same day
Since the trade −1.4% · S&P 500 −1.3% · to Nov 13
A Rapport Therapeutics director paid $100K out of pocket for Rapport Therapeutics shares. 6 other people at Rapport Therapeutics bought some too, in the same month. It was the first purchase in 13 months.
Insider buying
2 days before an 8-KTraded Oct 21 · filed 1 day later
Since the trade +9.2% · S&P 500 −2.4% · to Nov 13
A major shareholder of Dole paid $5.76M out of pocket for Dole shares.
Insider buying
13 days before resultsTraded Oct 20 · filed 2 days later
Since the trade +4.0% · S&P 500 −1.9% · to Nov 13
A major shareholder of Corebridge Financial paid $6.77M out of pocket for Corebridge Financial shares.
Traded Oct 22, 2026 · largest single transaction ~$217K
Oct 22, 2026~$217K · 8,239 sh @ $26.38
DetailsOfficial recordOct 22, 2026~$32K · 1,172 sh @ $26.92
DetailsOfficial recordInsider buying
3 insiders in a week, 2nd time since 2011Traded Jun 5 · filed 139 days later
Since the trade −70.0% · S&P 500 +2.3% · to Nov 13
A Liqtech International director paid $50K out of pocket for Liqtech International shares. 2 other people at Liqtech International bought some too, in the same month. Shares held went up 41% with this purchase.
Checked for new insider filings 2 h ago
